Biomonitor
Device Cardiology/Vascular Diseases
PDI 04035479177850
General payments
$426,789
Research payments
$400,533
Through program year 2025, $426,789 in general payments and $400,533 in research payments were reported against Biomonitor (Cardiology/Vascular Diseases).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $165,590 | 2,120 |
| 2025 | Research | $52,749 | 2 |
| 2024 | General | $152,303 | 1,933 |
| 2024 | Research | $79,955 | 13 |
| 2023 | General | $108,896 | 1,772 |
| 2023 | Research | $267,829 | 35 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 38 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 43 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
5,825 general · 50 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.